42 KomatsuM.KurokawaH.WaguriS.TaguchiK.KobayashiA.IchimuraY.et al (2010)
4554 years, OR 2.06, 95% CI = 1.42 to 3.02
Business Type Exporter, Supplier, Trading Company Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD, Cash Related Products Explore Related Categories More Products From This Seller Seller Details Altair 1, Purmerend, Noord-Holland, 1443, Netherlands The Compare With Similar Products Minimum Order Quantity 50 Vial/Vials 100 Piece/Pieces 10 Vial/Vials Indication Soft tissue injury, muscle recovery, inflammation management Tissue regeneration, injury recovery, muscle and tendon healing Pacakaging (Quantity Per Box) 1 vial per box 1 Vial / Box Life Span 24 months from date of manufacture 24 months from date of manufacture Dosage Form Injection Injection Lyophilized Powder for Injection Salt Composition BPC-157 Acetate Urofollitropin BPC 157 Drug Type Other, Peptide Injection Other, Peptide Therapeutic Ingredients BPC-157 (Pentadecapeptide) Acetate BPC 157 (Body Protective Compound-157) Function Other, Promotes tissue repair and healing, reduces inflammation Other, Musculoskeletal Healing, Tissue & Tendon Repair Recommended For Peptide Therapy, Tissue Repair, Anti-Inflammatory Support Adults Dosage As directed by healthcare professional 75 IU As prescribed by healthcare professional, commonly 2mg per vial Dosage Guidelines Inject subcutaneously or intramuscularly as advised Prescription For subcutaneous or intramuscular use only, as directed by physician Suitable For Adults Other, Men, Women, Aged Person Storage Instructions Store in a cool and dry place, protected from light, refrigerate after opening Cool & Dry Place Store in a cool and dry place, protect from light Payment Terms Cash in Advance (CID) Cash in Advance (CID) Supply Ability 1000 Per Month 5000 Per Month 1000 Per Month Price Or Price Range 290 INR (Approx.) 700 INR (Approx.) People Also Viewed
Setup and post-care typically add another 1015 minutes
Traditionally, peptides have been delivered through injections
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
